Income statement
USD
Annual
| Metric | 2025 | 2024 | 2022 | 2021 | 2021 |
|---|---|---|---|---|---|
| Revenue | 36M | 52M | 62M | 89M | 38M |
| Gross Profit | 0 | 40M | 54M | 75M | 31M |
| Operating Income | -8M | 2M | 6M | -23M | 774K |
| EBITDA | -8M | 7M | 12M | -20M | 4M |
| Net Income | -9M | 1M | -13M | -25M | 566K |
| EPS (Diluted) | — | — | — | — | — |
Technology
Live Price
Offline$25.49
+1.96% today
1Y Change
-2.00%
Window
Jun 23, 2025 → May 29, 2026
Coverage: 236 bars · Jun 23, 2025 → May 29, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Investview, Inc. (INVUP) is a Technology stock with a market cap of $47.05B and listed on OTC. The stock last traded around $25.49 and down 2.0% across the available one-year price window (Jun 23, 2025 → May 29, 2026). Baseline metrics include revenue growth of -30.8%, EPS growth of -5100.0%, a dividend yield of 0.0%. What stands out right now is revenue -30.8%, EPS -5100.0%, free cash flow -147.2% with operating margin -22.8% and ROIC -49.6%. Valuation is more restrained than many high-expectation growth names at price/sales 1.4. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines INVUP price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Technology peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
INVUP
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
INVUP Max Drawdown
-9.60%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for INVUP and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$38.3M
-57.1% YoY
FY Net Income
$565.8K
+102.3% YoY
Free Cash Flow
$4.0M
-87.0% YoY
Revenue Growth
-30.8%
EPS Growth
-5100.0%
Gross Margin
0.0%
Net Margin
-24.6%
Income statement
USD
| Metric | 2025 | 2024 | 2022 | 2021 | 2021 |
|---|---|---|---|---|---|
| Revenue | 36M | 52M | 62M | 89M | 38M |
| Gross Profit | 0 | 40M | 54M | 75M | 31M |
| Operating Income | -8M | 2M | 6M | -23M | 774K |
| EBITDA | -8M | 7M | 12M | -20M | 4M |
| Net Income | -9M | 1M | -13M | -25M | 566K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2022 | 2021 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 10M | 22M | 20M | 31M | 5M |
| Total Assets | 21M | 32M | 36M | 52M | 20M |
| Total Liabilities | 6M | 14M | 18M | 23M | 23M |
| Shareholder Equity | 9M | 17M | 17M | -73M | -4M |
| Total Debt | 1M | 3M | 11M | 0 | 16M |
| Net Debt | -9M | -19M | -10M | -31M | 11M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
7M
-79.1% YoY
Capital Expenditures
3M
-11.0% YoY
Free Cash Flow
4M
-87.0% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
-22.8%
Net Margin
-24.6%
ROE
-59.6%
Debt / Equity
0.14x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.